Influence of an SGLT2 inhibitor, tofogliflozin, on the resting heart rate in relation to adipose tissue insulin resistance

AIMS: To examine the effects of a sodium–glucose co‐transporter 2 (SGLT2) inhibitor, tofogliflozin, on resting heart rate by exploring baseline factors that independently influenced changes in the resting heart rate. METHODS: Data on 419 participants in tofogliflozin phase 2/3 trials were analysed....

Descripción completa

Detalles Bibliográficos
Autores principales: Nojima, T., Matsubayashi, Y., Yoshida, A., Suganami, H., Abe, T., Ishizawa, M., Fujihara, K., Tanaka, S., Kaku, K., Sone, H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7496771/
https://www.ncbi.nlm.nih.gov/pubmed/32096571
http://dx.doi.org/10.1111/dme.14279

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7496771/
https://www.ncbi.nlm.nih.gov/pubmed/32096571
http://dx.doi.org/10.1111/dme.14279

Ejemplares similares